Cellectar Biosciences, Inc. (NASDAQ: CLRB) announces that the Japan Patent Office has granted the patent titled "Phospholipid Analogs as Diapeutic Agents ...
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2C6eI2I
Cellectar Biosciences, Inc. (NASDAQ: CLRB) announces that the Japan Patent Office has granted the patent titled "Phospholipid Analogs as Diapeutic Agents ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.